Beyond Medical Technologies Net Income
| DOCKF Stock | USD 0.17 0.01 6.25% |
As of the 8th of February, Beyond Medical shows the Risk Adjusted Performance of 0.1342, mean deviation of 23.88, and Downside Deviation of 59.69. Beyond Medical Techn technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Beyond Medical Techn value at risk, as well as the relationship between the semi variance and kurtosis to decide if Beyond Medical Techn is priced correctly, providing market reflects its regular price of 0.17 per share. As Beyond Medical Techn appears to be a penny stock we also recommend to validate its total risk alpha numbers.
Beyond Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Beyond Medical's valuation are provided below:Gross Profit | Market Capitalization | Enterprise Value Revenue 0.3417 | Revenue | Earnings Share (0.07) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -2.6 M | -2.8 M | |
| Net Loss | -420.8 K | -441.8 K | |
| Net Loss | -328.8 K | -345.3 K |
Beyond | Net Income | Build AI portfolio with Beyond Stock |
The Net Income trend for Beyond Medical Technologies offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Beyond Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Beyond Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Beyond Medical Technologies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Beyond Medical Techn financial statement analysis. It represents the amount of money remaining after all of Beyond Medical Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Beyond Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Beyond Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (285.94 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Beyond Net Income Regression Statistics
| Arithmetic Mean | (5,203,330) | |
| Coefficient Of Variation | (68.26) | |
| Mean Deviation | 3,217,104 | |
| Median | (6,520,933) | |
| Standard Deviation | 3,551,767 | |
| Sample Variance | 12.6T | |
| Range | 8.2M | |
| R-Value | 0.91 | |
| Mean Square Error | 2.3T | |
| R-Squared | 0.83 | |
| Slope | 640,199 | |
| Total Sum of Squares | 201.8T |
Beyond Net Income History
Other Fundumenentals of Beyond Medical Techn
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Beyond Medical Net Income component correlations
Beyond Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Beyond Medical is extremely important. It helps to project a fair market value of Beyond Stock properly, considering its historical fundamentals such as Net Income. Since Beyond Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Beyond Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Beyond Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Can Industrial Machinery & Supplies & Components industry sustain growth momentum? Does Beyond have expansion opportunities? Factors like these will boost the valuation of Beyond Medical. Projected growth potential of Beyond fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Beyond Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.07) | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
Investors evaluate Beyond Medical Techn using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Beyond Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Beyond Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Beyond Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Beyond Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Beyond Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Beyond Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Beyond Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Beyond Medical.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Beyond Medical on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Beyond Medical Technologies or generate 0.0% return on investment in Beyond Medical over 90 days. Beyond Medical is related to or competes with Bion Environmental, Questor Technology, Environmmtl Tectonic, China High, Avante Logixx, and White Fox. Beyond Medical Technologies Inc. engages in the manufacturing and distribution of personal protective equipment in Canad... More
Beyond Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Beyond Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Beyond Medical Technologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 59.69 | |||
| Information Ratio | 0.1527 | |||
| Maximum Drawdown | 381.88 | |||
| Value At Risk | (36.00) | |||
| Potential Upside | 93.33 |
Beyond Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Beyond Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Beyond Medical's standard deviation. In reality, there are many statistical measures that can use Beyond Medical historical prices to predict the future Beyond Medical's volatility.| Risk Adjusted Performance | 0.1342 | |||
| Jensen Alpha | 8.77 | |||
| Total Risk Alpha | 3.14 | |||
| Sortino Ratio | 0.1452 | |||
| Treynor Ratio | (26.38) |
Beyond Medical February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1342 | |||
| Market Risk Adjusted Performance | (26.37) | |||
| Mean Deviation | 23.88 | |||
| Semi Deviation | 17.32 | |||
| Downside Deviation | 59.69 | |||
| Coefficient Of Variation | 648.01 | |||
| Standard Deviation | 56.74 | |||
| Variance | 3219.6 | |||
| Information Ratio | 0.1527 | |||
| Jensen Alpha | 8.77 | |||
| Total Risk Alpha | 3.14 | |||
| Sortino Ratio | 0.1452 | |||
| Treynor Ratio | (26.38) | |||
| Maximum Drawdown | 381.88 | |||
| Value At Risk | (36.00) | |||
| Potential Upside | 93.33 | |||
| Downside Variance | 3563.08 | |||
| Semi Variance | 299.84 | |||
| Expected Short fall | (86.58) | |||
| Skewness | 4.17 | |||
| Kurtosis | 20.41 |
Beyond Medical Techn Backtested Returns
Beyond Medical is out of control given 3 months investment horizon. Beyond Medical Techn secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We were able to collect data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 7.57% are justified by taking the suggested risk. Use Beyond Medical Mean Deviation of 23.88, risk adjusted performance of 0.1342, and Downside Deviation of 59.69 to evaluate company specific risk that cannot be diversified away. Beyond Medical holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.33, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Beyond Medical are expected to decrease at a much lower rate. During the bear market, Beyond Medical is likely to outperform the market. Use Beyond Medical value at risk, kurtosis, period momentum indicator, as well as the relationship between the semi variance and day median price , to analyze future returns on Beyond Medical.
Auto-correlation | 0.67 |
Good predictability
Beyond Medical Technologies has good predictability. Overlapping area represents the amount of predictability between Beyond Medical time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Beyond Medical Techn price movement. The serial correlation of 0.67 indicates that around 67.0% of current Beyond Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Beyond Net Income Applicable To Common Shares
Net Income Applicable To Common Shares |
|
Based on the recorded statements, Beyond Medical Technologies reported net income of (285,943). This is 100.11% lower than that of the Machinery sector and 103.87% lower than that of the Industrials industry. The net income for all United States stocks is 100.05% higher than that of the company.
Beyond Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beyond Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Beyond Medical could also be used in its relative valuation, which is a method of valuing Beyond Medical by comparing valuation metrics of similar companies.Beyond Medical is currently under evaluation in net income category among its peers.
Beyond Fundamentals
| Return On Equity | -3.14 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 3.96 M | ||||
| Shares Outstanding | 32.49 M | ||||
| Shares Owned By Insiders | 34.88 % | ||||
| Price To Earning | 38.84 X | ||||
| Price To Book | 3.96 X | ||||
| Price To Sales | 1.41 X | ||||
| Gross Profit | (250.49 K) | ||||
| EBITDA | (773.19 K) | ||||
| Net Income | (285.94 K) | ||||
| Cash And Equivalents | 877.31 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 60 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 3.73 X | ||||
| Book Value Per Share | 0.04 X | ||||
| Cash Flow From Operations | (109.77 K) | ||||
| Earnings Per Share | (0.07) X | ||||
| Target Price | 27.98 | ||||
| Beta | 9214.12 | ||||
| Market Capitalization | 12.65 M | ||||
| Total Asset | 13.8 K | ||||
| Retained Earnings | (26.38 M) | ||||
| Working Capital | (620.66 K) | ||||
| Net Asset | 13.8 K |
About Beyond Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beyond Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Can Industrial Machinery & Supplies & Components industry sustain growth momentum? Does Beyond have expansion opportunities? Factors like these will boost the valuation of Beyond Medical. Projected growth potential of Beyond fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Beyond Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.07) | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
Investors evaluate Beyond Medical Techn using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Beyond Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Beyond Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Beyond Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Beyond Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Beyond Medical's market price signifies the transaction level at which participants voluntarily complete trades.